Jeffrey T. Walsh, Chief Financial at bluebird bio, Inc. (BLUE), sold 70,000 shares at $150.46 ($10.6M) on 2017-11-01, disclosed to the SEC on 2017-11-03.
Open-market sale of $10.6M BLUE by Chief Financial. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $150.46 | 10,775 | $1.6M | 15.3% |
| 2 | $150.46 | 10,775 | $1.6M | 15.3% |
| 3 | $151.45 | 15,462 | $2.3M | 22.1% |
| 4 | $151.45 | 15,462 | $2.3M | 22.1% |
| 5 | $152.30 | 7,789 | $1.2M | 11.2% |
| 6 | $152.30 | 7,789 |
| $1.2M |
| 11.2% |
| 7 | $153.10 | 974 | $149K | 1.4% |
| 8 | $153.10 | 974 | $149K | 1.4% |
| Total | $151.38 avg | 70,000 | $10.6M | 100% |
| Filing → |
| BLUE | SELL | 2019-06-12 | $176K | — | Filing → |
| BLUE | SELL | 2019-05-14 | $198K | — | Filing → |
| BLUE | SELL | 2019-04-12 | $298K | — | Filing → |